4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-005231
CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.58 ($38,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-08-01 | Purchase | +15,000 | $2.58 | $38,700 | 5,346,873 | D |
| Open-market purchases · 15,000 sh · avg $2.58 · $38,700 | |||||||
Loading xslF345X03/ownership.xml…